16 Hrs
Source:
The Boston Globe
_1777370193195_831968492.png&w=48&q=75){kind=small}
GLP-1 dilemma: stigma or benefit
The article primarily discusses the social and cultural implications surrounding the use of GLP-1 weight-loss drugs like Ozempic. It highlights the social judgment faced by users who are scrutinized whether they take the medication or not, amid rising aesthetic standards demanding more than just being slim. The piece also explores the increasing emphasis on muscular ideals and the rising costs associated with achieving these body images.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)